CAN
EVOK

Cetera Advisor Networks’s Evoke Pharma EVOK Stock Holding History

Cetera Advisor Networks’s Portfolio EVOK Stock Details EVOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-210
Closed -$78K – 1498
2020
Q4 		$78K Hold
210
– – ﹤0.01% 1320
2020
Q3 		$142K Hold
210
– – ﹤0.01% 1176
2020
Q2 		$107K Buy
210
+14
+7% +$3.89K ﹤0.01% 1467
2020
Q1 		$33K Buy
196
+102
+109% +$19.6K ﹤0.01% 1100
2019
Q4 		$22K Buy
94
+25
+36% +$4.28K ﹤0.01% 1240
2019
Q3 		$9K Buy
+69
New +$9.25K ﹤0.01% 1194

Other funds holding EVOK

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
WA
Wambolt & Associates Littleton, Colorado $297M AUM 17.23% 1-Year Est. Return

Cetera Advisor Networks's EVOK Position: Q1 2021 in Review

Cetera Advisor Networks sold out of Evoke Pharma (EVOK) in Q1 2021, closing a stake of 210 shares — an estimated $78K sold.

Cetera Advisor Networks first reported a position in EVOK in Q3 2019 and held it in 6 quarters. The position peaked at $142K in Q3 2020. 25 funds tracked by Wall St. Rank hold EVOK as of Q1 2021.

  • Cetera Advisor Networks reported no remaining Evoke Pharma position as of Q1 2021 after selling out during the quarter.
  • Cetera Advisor Networks sold 210 Evoke Pharma shares in Q1 2021, an estimated $78K.
  • Cetera Advisor Networks first reported a position in Evoke Pharma in Q3 2019 and held it in 6 quarters.
  • Cetera Advisor Networks's Evoke Pharma position peaked at $142K in Q3 2020.
  • 25 funds tracked by Wall St. Rank held Evoke Pharma as of Q1 2021.

Based on Cetera Advisor Networks's 13F filing for Q1 2021, filed 17 May 2021.